Skip to main navigation
Skip to search
Skip to main content
Research Nebraska Home
Help & FAQ
Home
Profiles
Research units
Facilities and Equipment
Research output
Projects
Activities
Prizes
Search by expertise, name or affiliation
Ciltacabtagene autoleucel for the treatment of multiple myeloma
Sarah A. Holstein
Oncology/Hematology
Oncology, Nebraska Medicine
James O Armitage Center for Hematological Malignancies Research
Great Plains IDeA-CTR
Center for Molecular Target Discovery & Development
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ciltacabtagene autoleucel for the treatment of multiple myeloma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
B-Cell Maturation Antigen
100%
Chimeric Antigen Receptors
77%
Multiple Myeloma
56%
Cell- and Tissue-Based Therapy
54%
T-Lymphocytes
35%
United States Food and Drug Administration
28%
Clinical Trials
18%
Therapeutics
9%